series-a
Stage
1
Investors
About
Cajal Neuroscience is a biotechnology company focused on accelerating drug discovery for neurodegenerative diseases. The company integrates human genetics, functional genomics, and advanced microscopy to identify novel therapeutic targets and validate them at an unprecedented scale.
Explore Cajal Neuroscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.